Literature DB >> 519427

Cancer chemotherapy--the inbuilt deterrent.

.   

Abstract

Mesh：

Substances：

Year:  1979        PMID： 519427      PMCID： PMC1597312          DOI： 10.1136/bmj.2.6201.1312

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  6 in total

1.  Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.

Authors:  T S Herman; L H Einhorn; S E Jones; C Nagy; A B Chester; J C Dean; B Furnas; S D Williams; S A Leigh; R T Dorr; T E Moon
Journal:  N Engl J Med       Date:  1979-06-07       Impact factor: 91.245

2.  Incidence of nausea and vomiting with cytotoxic chemotherapy: a prospective randomised trial of antiemetics.

Authors:  C Morran; D C Smith; D A Anderson; C S McArdle
Journal:  Br Med J       Date:  1979-05-19

3.  Controlled clinical studies of orally administered antiemetic drugs.

Authors:  C G Moertel; R J Reitemeier
Journal:  Gastroenterology       Date:  1969-09       Impact factor: 22.682

4.  Clinical and psychological effects of marihuana in man.

Authors:  A T Weil; N E Zinberg; J M Nelsen
Journal:  Science       Date:  1968-12-13       Impact factor: 47.728

5.  Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy.

Authors:  S E Sallan; N E Zinberg; E Frei
Journal:  N Engl J Med       Date:  1975-10-16       Impact factor: 91.245

6.  Nabilone: a potent antiemetic cannabinol with minimal euphoria.

Authors:  T S Herman; S E Jones; J Dean; S Leigh; R Dorr; T E Moon; S E Salmon
Journal:  Biomedicine       Date:  1977-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.